Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.62 USD | +0.08% | -0.24% | +3.95% |
22/05 | Evotec Shares Rise Following Gene Therapy Exit, Q1 Results | MT |
22/05 | Evotec Q1 Net Loss Widens as Revenue Falls | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+3.95% | 0 | |
+6.64% | 1.31TCr | |
+11.21% | 949.45Cr | |
+0.75% | 563.49Cr | |
+5.94% | 544.02Cr | |
+7.52% | 528.22Cr | |
+27.97% | 501.64Cr | |
+22.98% | 468.56Cr | |
+2.89% | 408.35Cr | |
+5.60% | 398.52Cr |
- Stock Market
- Equities
- EVO Stock
- News Eaton Vance Ohio Municipal Income Trust
- Evotec's Preliminary 2022 Operating Income Declines, Revenue Rises